Our single-cell and cohort analyses collectively support a stromal-myeloid axis in which fibroblast-derived WISP-1 promotes STAT1 activation in M2-like TAMs within the NSCLC microenvironment. Here, STAT1 is linked to non-small cell lung carcinoma.